Literature DB >> 30457883

Pathologies of matrix metalloproteinase-2 underactivity: a perspective on a neglected condition 1.

Ryan Cook1, Hassan Sarker1, Carlos Fernandez-Patron2.   

Abstract

A member of the matrix metalloproteinase family, matrix metalloproteinase-2 (MMP-2, gelatinase A), has been extensively studied for its role in both normal physiology and pathological processes. Whereas most research efforts in recent years have investigated the pathologies associated with MMP-2 overactivity, the pathological mechanisms elicited by MMP-2 underactivity are less well understood. Here, we distinguish between 2 states and describe their causes: (i) MMP-2 deficiency (complete loss of MMP-2 activity) and (ii) MMP-2 insufficiency (defined as MMP-2 activity below baseline levels). Further, we review the biology of MMP-2, summarizing the current literature on MMP-2 underactivity in both mice and humans, and describe research being conducted by our lab towards improving our understanding of the pathological mechanisms elicited by MMP-2 deficiency/insufficiency. We think that this research could stimulate the discovery of new therapeutic approaches for managing pathologies associated with MMP-2 underactivity. Moreover, similar concepts could apply to other members of the matrix metalloproteinase family.

Entities:  

Keywords:  MMP; MMP-2 deficiency; défaut de MMP-2; inflammation; metabolism; métabolisme

Mesh:

Substances:

Year:  2018        PMID: 30457883     DOI: 10.1139/cjpp-2018-0525

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  1 in total

Review 1.  The Emerging Role of Epigenetic Mechanisms in the Causation of Aberrant MMP Activity during Human Pathologies and the Use of Medicinal Drugs.

Authors:  Hassan Sarker; Ayman Haimour; Ravneet Toor; Carlos Fernandez-Patron
Journal:  Biomolecules       Date:  2021-04-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.